Balloon dilatation for treatment of resistant nasolacrimal duct obstruction

K A Hutcheson; A V Drack; S R Lambert

doi:10.1016/S1091-8531(97)90045-8

Back

Balloon dilatation for treatment of resistant nasolacrimal duct obstruction

Journal article

Peer reviewed

Balloon dilatation for treatment of resistant nasolacrimal duct obstruction

K A Hutcheson, A V Drack and S R Lambert

Journal of AAPOS, Vol.1(4), pp.241-244

12/1997

DOI: 10.1016/S1091-8531(97)90045-8

PMID: 10532771

View Online

Abstract

Our purpose was to report our experience with balloon catheter dilatation for resistant nasolacrimal duct obstruction. Patients enrolled had symptoms of nasolacrimal duct obstruction and (1) had failed previous probing or (2) were more than 2 years old. Balloon dilatation was performed with a LacriCATH lacrimal catheter (Atrion Medical Products, Birmingham, Ala.). A subset of patients had Silastic silicone rubber (Dow Corning, Midland, Mich.) intubation after balloon dilatation. Success was determined by clinical examination a minimum of 6 weeks later. Twenty-one lacrimal systems of 12 patients were treated (age range 4 months to 7 years). Of the patient subset treated with a LacriCATH lacrimal catheter alone, 9 of 18 systems demonstrated complete resolution of symptoms. Three of the 12 patients underwent balloon dilatation intraoperatively after attempts at Silastic silicone rubber intubation were unsuccessful. In two of these patients, who were younger, Silastic silicone rubber tubes passed easily after balloon treatment; however, in an older patient, age 5 years, intubation still could not be accomplished. Common clinical strategy for treatment of resistant nasolacrimal obstruction includes repeat probing, intubation of the nasolacrimal system with Silastic silicone rubber tubes, or dacryocystorhinostomy. Balloon catheter dilatation is an alternative or adjunct to consider. Factors that may affect the success of treatment include the age of the patient, the complexity of the nasolacrimal anatomy, and use of adjunctive systemic antibiotics and steroids.

Catheterization

Humans

Lacrimal Duct Obstruction - therapy

Child, Preschool

Infant

Treatment Outcome

Nasolacrimal Duct

Intubation

Details

Title: Subtitle: Balloon dilatation for treatment of resistant nasolacrimal duct obstruction
Creators: K A Hutcheson - Emory Eye Center, Emory University, Atlanta, GA 30322, USA
A V Drack
S R Lambert
Resource Type: Journal article
Publication Details: Journal of AAPOS, Vol.1(4), pp.241-244
DOI: 10.1016/S1091-8531(97)90045-8
PMID: 10532771
NLM abbreviation: J AAPOS
ISSN: 1091-8531
eISSN: 1528-3933
Publisher: Elsevier Inc; United States
Grant note: P30 EY06360 / NEI NIH HHS
Language: English
Date published: 12/1997
Academic Unit: Stead Family Department of Pediatrics; Ophthalmology and Visual Sciences
Record Identifier: 9983979986002771

Metrics

30 Record Views